Publication

Article

Cardiology Review® Online

March 2008
Volume25
Issue 3

Continuing Medical Education Exam

Target: Lipids and CAD

From "

"

Nonfasting triglycerides and ischemic heart disease in men and women

Learning objectives

Describe the utility of measuring fasting versus nonfasting triglyceride levels for predicting the risk of myocardial infarction (MI), ischemic heart disease, and death in the general population and noting sex-related differences.

Questions

  1. At moderate hypertriglyceridemia, chylomicron remnants and ______ enter into the arterial intima, appear to be preferentially trapped with the arterial wall, and thus may cause atherosclerosis leading to MI, ischemic heart disease, and ultimately, death. low-density lipoproteins very-low-density lipoproteins intermediate-density lipoproteins high-density lipoproteins.
  2. In this prospective cohort study, age-adjusted hazard ratios were more pronounced in men with entry age of ≤55 years versus those >55 years and in _________. nonsmokers versus smokers those without familial heart disease versus those with familial cardiovascular disease those with a body mass index (BMI) <30 versus those with a BMI >30 light versus heavy alcohol drinkers
  3. The study found that nonfasting triglycerides ≥5 mmol/L predict a _____ and _____ fold risk of MI in men and women in the general population, respectively. 3-; 6- 2-; 4- 5-; 17- 4-; 10-
  4. Subanalyses of 3 randomized double-blind trials suggest that among patients with elevated triglycerides, a ________ reduction in triglyceride levels associate with a 30% to 40% reduction in risk of ischemic heart disease. 5 to 10% 10 to 20% 15 to 30% 20 to 40%
  5. According to the author, all but which of the following are considered advantages of this study? The sample was ethnically heterogeneous There was a high participation rate The authors had 26 years 100% complete follow-up The authors corrected for regression dilution bias

To take this exam, you can

. Cardiology Review materials are posted to that site on a continuous basis (registration required).

download the CME answer form (PDF) and mail, fax, or email it to address given; or go to the University of Cincinnati's Center for Continuous Professional Development

Target: Heart Failure

From "

"

Serial biomarker measurements in chronic heart failure

Learning objectives

Explain the value of using serial measurements of cardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) over several years to estimate prognosis in heart failure.

Questions

  1. In this cohort study of 190 subjects with NYHA class III and IV heart failure, survival for subjects with a cardiac troponin T (cTnT) level of more than _____ at any point during the study was significantly worse. 0.01 ng/mL 0.02 ng/mL 0.03 ng/mL 0.04 ng/mL
  2. In the study, there was a 3.38-fold greater risk of death or cardiac transplantation among subjects with an increased cTnT level above ________ from one follow-up visit to the next or if subjects had a persistently elevated cTnT level. 0.01 ng/mL 0.02 ng/mL 0.03 ng/mL 0.04 ng/mL
  3. Over time, increased B-type natriuretic peptide (BNP levels) did not have the same effect as increased cTnT levels. Although subjects with new elevations above normal had greater risk, once the BNP level was elevated, further increases or decreases did not make any difference. Long-term observation of BNP levels might, therefore, not be effective. This could be the result of the fact that the subjects in this study had _____ instead of acutely decompensated heart failure. cardiomyopathy chronic arrhythmia ischemic heart disease chronic stable heart failure
  4. The combination of increased BNP and cTnT levels resulted in a ______ greater risk of death or cardiac transplantation. 8-fold 6-fold 4-fold 2-fold
  5. The patient in the case study presented with a fairly moderate degree of decompensated chronic heart failure (BNP level of 1152 pg/mL and a cTnT level of 0.09 ng/mL). In addition to fluid and sodium restriction, he was treated with an increased daily dose of _________. At his follow-up visit 4 weeks later, his BNP level was 240 pg/mL and his cTnT level was <0.01 ng/mL. spironolactone furosemide amiloride hydrochlorothiazide

To take this exam, you can

. Cardiology Review materials are posted to that site on a continuous basis (registration required).

download the CME answer form (PDF) and mail, fax, or email it to address given; or go to the University of Cincinnati's Center for Continuous Professional Development

Related Videos
The APAC Recap: Cardiomyopathy at CAPP Live 2024 with Greg Duck, PA-C | Image Credit: APAC
The APAC Recap: Peripheral Artery Disease at CAPP Live 2024 with Bob Ross, PA-C | Image Credit: APAC
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.